Lanzamiento Enero 2027

Ensayo controlado aleatorizado2026Acceso abierto

Krill oil increases plasma omega-3 fatty acids more than fish oil in healthy adults: a double-blind randomized controlled trial

Loukil I, Vachon A, Çaku A, Plourde M

The American journal of clinical nutrition · 1 cita

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
Canadian Institutes of Health Research
Universidad u hospital
Institute of Nutrition, Metabolism and Diabetes
Universidad u hospital
Institute of Nutrition Metabolism and Diabetes
Subvenciones
Institute of Nutrition, Metabolism and Diabetes (201909PJ)

Según 3 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2026-05-16 · Am J Clin Nutr · vol. 124 · número 1 · pág. 101346
Editorial
Elsevier BV
Citado
1 cita · más que el 93% de estudios similares · 4.4× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
44 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY-NC-ND
Áreas de investigación
Fatty Acid Research and Health · Edible Oils Quality and Analysis · Aquaculture Nutrition and Growth
Palabras clave
krill oil, fish oil, omega-3 fatty acids, EPA, docosahexaenoic acid, plasma fatty acid concentrations, APOE ε4, sex differences, dietary supplementation, healthy adults
MeSH
animals, humans, euphausiacea, fatty acids, omega-3, docosahexaenoic acids, eicosapentaenoic acid, fish oils, double-blind method, genotype, dietary supplements, adult, middle aged, female, male, apolipoprotein e4, young adult

4 autores

  • Insaf Loukil🇨🇦Université de Sherbrooke; Université Laval; Centre de recherche sur le vieillissement; Institut sur la nutrition et les aliments fonctionnels (INAF)
  • Annick Vachon🇨🇦Université de Sherbrooke; Université Laval; Centre de recherche sur le vieillissement; Institut sur la nutrition et les aliments fonctionnels (INAF)
  • Artuela Çaku🇨🇦Université de Sherbrooke
  • Mélanie Plourde🇨🇦 · autor de correspondenciaUniversité de Sherbrooke; Université Laval; Centre de recherche sur le vieillissement; Institut sur la nutrition et les aliments fonctionnels (INAF)

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Omega-3 fatty acids (ω-3 FAs), particularly EPA and DHA, are recognized for their health benefits. However, their circulating levels after supplementation may be modulated by several factors, including sex, carriage of the apolipoprotein E ε4 (APOE4) allele, and the chemical form of the supplement. Krill oil delivers ω-3 FAs primarily as phospholipids, whereas fish oil provides them as triglycerides.

Objectives

This study aimed to compare EPA and DHA concentrations after supplementation with krill oil and fish oil and assess whether sex and APOE4 genotype modify responses to supplementation.

Methods

This double-blind, randomized clinical trial included 72 healthy adults (53 females, 19 males) matched for age and BMI. Participants received 1.1 g/d ω-3 FAs through either krill oil (n = 36) or fish oil (n = 36) for 12 wk. Plasma FAs were measured at baseline and at weeks 1, 2, 4, and 12 by GC-flame ionization detection. Differences in plasma ω-3 FAs concentrations by treatment, sex, and APOE4 status were analyzed.

Results

Time-by-treatment interactions were significant for plasma delta over baseline concentrations of EPA (P = 0.0001) and DHA (P = 0.005), with krill oil resulting in ∼1.5-fold higher Δ EPA and Δ DHA compared with fish oil. The time-by-sex interaction was significant only for EPA (P = 0.026), with females having a 1.5-fold greater increase than males at 12 wk. After supplementation with either krill oil or fish oil, APOE4 carriers had 3-fold and 1.6-fold higher EPA and DHA, respectively, compared with baseline; however, these increases were not significantly different from those found in noncarriers.

Conclusions

Krill oil increased plasma ω-3 FAs more than fish oil, regardless of APOE4 genotype. Individuals with higher ω-3 FA requirements may achieve adequate enrichment with lower doses of krill oil compared with fish oil supplementation. This trial was registered at clinicaltrials.gov as NCT04279743.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-ND).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.